PUBLISHER: QYResearch | PRODUCT CODE: 1609304
PUBLISHER: QYResearch | PRODUCT CODE: 1609304
This research report focuses on the Gadoterate Meglumine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
Table 1. Global Gadoterate Meglumine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 1.8845Gm/5Ml
Table 3. Major Manufacturers of 3.769Gm/10Ml
Table 4. Major Manufacturers of 5.6535Gm/15Ml
Table 5. Major Manufacturers of Others
Table 6. Global Gadoterate Meglumine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Gadoterate Meglumine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Gadoterate Meglumine Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Gadoterate Meglumine Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Gadoterate Meglumine Revenue Market Share by Region (2019-2024)
Table 11. Global Gadoterate Meglumine Revenue Market Share by Region (2025-2030)
Table 12. Global Gadoterate Meglumine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K L)
Table 13. Global Gadoterate Meglumine Sales by Region (2019-2024) & (K L)
Table 14. Global Gadoterate Meglumine Sales by Region (2025-2030) & (K L)
Table 15. Global Gadoterate Meglumine Sales Market Share by Region (2019-2024)
Table 16. Global Gadoterate Meglumine Sales Market Share by Region (2025-2030)
Table 17. Global Gadoterate Meglumine Sales by Manufacturers (2019-2024) & (K L)
Table 18. Global Gadoterate Meglumine Sales Share by Manufacturers (2019-2024)
Table 19. Global Gadoterate Meglumine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Gadoterate Meglumine, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Gadoterate Meglumine Price by Manufacturers (2019-2024) & (US$/L)
Table 23. Global Gadoterate Meglumine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadoterate Meglumine as of 2023)
Table 25. Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Gadoterate Meglumine, Product Offered and Application
Table 27. Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Gadoterate Meglumine Sales by Type (2019-2024) & (K L)
Table 30. Global Gadoterate Meglumine Sales by Type (2025-2030) & (K L)
Table 31. Global Gadoterate Meglumine Sales Share by Type (2019-2024)
Table 32. Global Gadoterate Meglumine Sales Share by Type (2025-2030)
Table 33. Global Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Gadoterate Meglumine Revenue Share by Type (2019-2024)
Table 36. Global Gadoterate Meglumine Revenue Share by Type (2025-2030)
Table 37. Gadoterate Meglumine Price by Type (2019-2024) & (US$/L)
Table 38. Global Gadoterate Meglumine Price Forecast by Type (2025-2030) & (US$/L)
Table 39. Global Gadoterate Meglumine Sales by Application (2019-2024) & (K L)
Table 40. Global Gadoterate Meglumine Sales by Application (2025-2030) & (K L)
Table 41. Global Gadoterate Meglumine Sales Share by Application (2019-2024)
Table 42. Global Gadoterate Meglumine Sales Share by Application (2025-2030)
Table 43. Global Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Gadoterate Meglumine Revenue Share by Application (2019-2024)
Table 46. Global Gadoterate Meglumine Revenue Share by Application (2025-2030)
Table 47. Gadoterate Meglumine Price by Application (2019-2024) & (US$/L)
Table 48. Global Gadoterate Meglumine Price Forecast by Application (2025-2030) & (US$/L)
Table 49. US & Canada Gadoterate Meglumine Sales by Type (2019-2024) & (K L)
Table 50. US & Canada Gadoterate Meglumine Sales by Type (2025-2030) & (K L)
Table 51. US & Canada Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Gadoterate Meglumine Sales by Application (2019-2024) & (K L)
Table 54. US & Canada Gadoterate Meglumine Sales by Application (2025-2030) & (K L)
Table 55. US & Canada Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Gadoterate Meglumine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 61. US & Canada Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 62. Europe Gadoterate Meglumine Sales by Type (2019-2024) & (K L)
Table 63. Europe Gadoterate Meglumine Sales by Type (2025-2030) & (K L)
Table 64. Europe Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Gadoterate Meglumine Sales by Application (2019-2024) & (K L)
Table 67. Europe Gadoterate Meglumine Sales by Application (2025-2030) & (K L)
Table 68. Europe Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Gadoterate Meglumine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 74. Europe Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 75. China Gadoterate Meglumine Sales by Type (2019-2024) & (K L)
Table 76. China Gadoterate Meglumine Sales by Type (2025-2030) & (K L)
Table 77. China Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Gadoterate Meglumine Sales by Application (2019-2024) & (K L)
Table 80. China Gadoterate Meglumine Sales by Application (2025-2030) & (K L)
Table 81. China Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Gadoterate Meglumine Sales by Type (2019-2024) & (K L)
Table 84. Asia Gadoterate Meglumine Sales by Type (2025-2030) & (K L)
Table 85. Asia Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Gadoterate Meglumine Sales by Application (2019-2024) & (K L)
Table 88. Asia Gadoterate Meglumine Sales by Application (2025-2030) & (K L)
Table 89. Asia Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Gadoterate Meglumine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Gadoterate Meglumine Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Gadoterate Meglumine Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Gadoterate Meglumine Sales by Region (2019-2024) & (K L)
Table 95. Asia Gadoterate Meglumine Sales by Region (2025-2030) & (K L)
Table 96. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Type (2019-2024) & (K L)
Table 97. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Type (2025-2030) & (K L)
Table 98. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Application (2019-2024) & (K L)
Table 101. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Application (2025-2030) & (K L)
Table 102. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 108. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 109. Guerbet Group Company Information
Table 110. Guerbet Group Description and Major Businesses
Table 111. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 112. Guerbet Group Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Guerbet Group Recent Developments
Table 114. Hengrui Medicine Company Information
Table 115. Hengrui Medicine Description and Major Businesses
Table 116. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 117. Hengrui Medicine Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Hengrui Medicine Recent Developments
Table 119. GE Healthcare Company Information
Table 120. GE Healthcare Description and Major Businesses
Table 121. GE Healthcare Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 122. GE Healthcare Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. GE Healthcare Recent Developments
Table 124. Key Raw Materials Lists
Table 125. Raw Materials Key Suppliers Lists
Table 126. Gadoterate Meglumine Distributors List
Table 127. Gadoterate Meglumine Customers List
Table 128. Gadoterate Meglumine Market Trends
Table 129. Gadoterate Meglumine Market Drivers
Table 130. Gadoterate Meglumine Market Challenges
Table 131. Gadoterate Meglumine Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Figure 1. Gadoterate Meglumine Product Picture
Figure 2. Global Gadoterate Meglumine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gadoterate Meglumine Market Share by Type: 2023 & 2030
Figure 4. 1.8845Gm/5Ml Product Picture
Figure 5. 3.769Gm/10Ml Product Picture
Figure 6. 5.6535Gm/15Ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gadoterate Meglumine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Gadoterate Meglumine Market Share by Application: 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Gadoterate Meglumine Report Years Considered
Figure 13. Global Gadoterate Meglumine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 15. Global Gadoterate Meglumine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 16. Global Gadoterate Meglumine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Gadoterate Meglumine Revenue Market Share by Region (2019-2030)
Figure 18. Global Gadoterate Meglumine Sales (2019-2030) & (K L)
Figure 19. Global Gadoterate Meglumine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K L)
Figure 20. Global Gadoterate Meglumine Sales Market Share by Region (2019-2030)
Figure 21. US & Canada Gadoterate Meglumine Sales YoY (2019-2030) & (K L)
Figure 22. US & Canada Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Europe Gadoterate Meglumine Sales YoY (2019-2030) & (K L)
Figure 24. Europe Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. China Gadoterate Meglumine Sales YoY (2019-2030) & (K L)
Figure 26. China Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Asia (excluding China) Gadoterate Meglumine Sales YoY (2019-2030) & (K L)
Figure 28. Asia (excluding China) Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Gadoterate Meglumine Sales YoY (2019-2030) & (K L)
Figure 30. Middle East, Africa and Latin America Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Global Gadoterate Meglumine Sales Share by Manufacturers (2023)
Figure 32. The Gadoterate Meglumine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. Global Gadoterate Meglumine Revenue Share by Manufacturers (2023)
Figure 34. The Top 5 and 10 Largest Manufacturers of Gadoterate Meglumine in the World: Market Share by Gadoterate Meglumine Revenue in 2023
Figure 35. Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 36. Global Gadoterate Meglumine Sales Market Share by Type (2019-2030)
Figure 37. Global Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
Figure 38. Global Gadoterate Meglumine Sales Market Share by Application (2019-2030)
Figure 39. Global Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Gadoterate Meglumine Sales Market Share by Type (2019-2030)
Figure 41. US & Canada Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
Figure 42. US & Canada Gadoterate Meglumine Sales Market Share by Application (2019-2030)
Figure 43. US & Canada Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
Figure 44. US & Canada Gadoterate Meglumine Revenue Share by Country (2019-2030)
Figure 45. US & Canada Gadoterate Meglumine Sales Share by Country (2019-2030)
Figure 46. US Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 47. Canada Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 48. Europe Gadoterate Meglumine Sales Market Share by Type (2019-2030)
Figure 49. Europe Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
Figure 50. Europe Gadoterate Meglumine Sales Market Share by Application (2019-2030)
Figure 51. Europe Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
Figure 52. Europe Gadoterate Meglumine Revenue Share by Country (2019-2030)
Figure 53. Europe Gadoterate Meglumine Sales Share by Country (2019-2030)
Figure 54. Germany Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 55. France Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 56. U.K. Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 57. Italy Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 58. Russia Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 59. China Gadoterate Meglumine Sales Market Share by Type (2019-2030)
Figure 60. China Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
Figure 61. China Gadoterate Meglumine Sales Market Share by Application (2019-2030)
Figure 62. China Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
Figure 63. Asia Gadoterate Meglumine Sales Market Share by Type (2019-2030)
Figure 64. Asia Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
Figure 65. Asia Gadoterate Meglumine Sales Market Share by Application (2019-2030)
Figure 66. Asia Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
Figure 67. Asia Gadoterate Meglumine Revenue Share by Region (2019-2030)
Figure 68. Asia Gadoterate Meglumine Sales Share by Region (2019-2030)
Figure 69. Japan Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 70. South Korea Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 71. China Taiwan Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 72. Southeast Asia Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 73. India Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 74. Australia Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 75. Middle East, Africa and Latin America Gadoterate Meglumine Sales Market Share by Type (2019-2030)
Figure 76. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
Figure 77. Middle East, Africa and Latin America Gadoterate Meglumine Sales Market Share by Application (2019-2030)
Figure 78. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
Figure 79. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Share by Country (2019-2030)
Figure 80. Middle East, Africa and Latin America Gadoterate Meglumine Sales Share by Country (2019-2030)
Figure 81. Brazil Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 82. Mexico Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 83. Turkey Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 84. Israel Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 85. GCC Countries Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)
Figure 86. Gadoterate Meglumine Value Chain
Figure 87. Gadoterate Meglumine Production Process
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed